- Home
- CDRE vs BHVN Comparison
CDRE vs BHVN Comparison
Compare CDRE & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDRE
- BHVN
- Stock Information
- Founded
- CDRE 2012
- BHVN 2013
- Country
- CDRE United States
- BHVN United States
- Employees
- CDRE N/A
- BHVN N/A
- Industry
- CDRE Industrial Specialties
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- CDRE Health Care
- BHVN Health Care
- Exchange
- CDRE Nasdaq
- BHVN Nasdaq
- Market Cap
- CDRE 1.3B
- BHVN 1.5B
- IPO Year
- CDRE 2021
- BHVN 2017
- Fundamental
- Price
- CDRE $31.96
- BHVN $15.86
- Analyst Decision
- CDRE Buy
- BHVN Strong Buy
- Analyst Count
- CDRE 2
- BHVN 15
- Target Price
- CDRE $31.50
- BHVN $56.07
- AVG Volume (30 Days)
- CDRE 319.9K
- BHVN 2.1M
- Earning Date
- CDRE 08-05-2025
- BHVN 08-11-2025
- Dividend Yield
- CDRE 1.18%
- BHVN N/A
- EPS Growth
- CDRE N/A
- BHVN N/A
- EPS
- CDRE 0.93
- BHVN N/A
- Revenue
- CDRE $572,607,000.00
- BHVN N/A
- Revenue This Year
- CDRE $12.55
- BHVN N/A
- Revenue Next Year
- CDRE $7.57
- BHVN $2,002.87
- P/E Ratio
- CDRE $34.67
- BHVN N/A
- Revenue Growth
- CDRE 7.66
- BHVN N/A
- 52 Week Low
- CDRE $27.07
- BHVN $12.79
- 52 Week High
- CDRE $40.28
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- CDRE 55.82
- BHVN 55.58
- Support Level
- CDRE $30.24
- BHVN $15.28
- Resistance Level
- CDRE $31.26
- BHVN $17.25
- Average True Range (ATR)
- CDRE 0.82
- BHVN 0.85
- MACD
- CDRE 0.29
- BHVN 0.08
- Stochastic Oscillator
- CDRE 86.83
- BHVN 53.97
About CDRE Cadre Holdings Inc.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.